Press Release

View printer-friendly version

<< Back

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the following investor conferences:

  • Jefferies London Healthcare Conference
    Thursday, November 15, 2018 at 8:00 a.m. GMT (3:00 a.m. ET)
    Location: London, U.K.

  • Piper Jaffray Healthcare Conference
    Tuesday, November 27, 2018 at 8:00 a.m. ET
    Location: New York, NY

To access the live webcasts, please visit the Investors section of the company’s website at www.amagpharma.com. A replay of each webcast will be archived on the site for 30 days.

About AMAG
AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs. The company does this by leveraging its development and commercial expertise to invest in and grow its pharmaceutical products across a range of therapeutic areas, including women’s health. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. 

AMAG Pharmaceuticals Contact:
Christi Waarich
781-697-0308

AMAG Pharmaceuticals logo

Source: AMAG Pharmaceuticals, Inc.